Adjunctive Fosfomycin for the Treatment of <i>Staphylococcus aureus</i> Bacteremia: A Pooled Post Hoc Analysis of Individual Participant Data From 2 Randomized Trials

Adjunctive fosfomycin may improve early bacterial clearance and treatment success in SAB but at the cost of increased toxicity. Clinical Trials Registration. NCT06695832.

Authors

Institutions

Publication Details

Journal
Clinical Infectious Diseases
Published
2025-07-16
DOI
https://doi.org/10.1093/cid/ciaf387
Citations
2
Primary Topic
Antimicrobial Resistance in Staphylococcus
Type
article
Field-Weighted Citation Impact
2.79

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Adjunctive Fosfomycin for the Treatment of Staphylococcus aureus Bacteremia: A Pooled Post Hoc Analysis of Individual Participant Data From 2 Randomized Trials

Sean Wei Xiang Ong, S. Tong, Isabel Oriol, Jordi Carratalà et al.
2 citations
Clinical Infectious Diseases
Antimicrobial Resistance in Staphylococcus
2.79
article

Adjunctive Fosfomycin for the Treatment of Staphylococcus aureus Bacteremia: A Pooled Post Hoc Analysis of Individual Participant Data From 2 Randomized Trials

Sean Wei Xiang Ong, S. Tong, Isabel Oriol, Jordi Carratalà, Sara Grillo, Francesc Escrihuela-Vidal, Miquel Pujol, Natàlia Pallarés, Kuan Liu, José M. Miró, Cristian Tebé
article en
2 citations

Abstract

Adjunctive fosfomycin may improve early bacterial clearance and treatment success in SAB but at the cost of increased toxicity. Clinical Trials Registration. NCT06695832.

Clinical Infectious DiseasesVol. 82(2)
Universitat Autònoma de Barcelona (ES), Real Academia Española (ES), The Royal Melbourne Hospital (AU), Sunnybrook Health Science Centre (CA), The University of Melbourne (AU), University of Toronto (CA), Instituto de Salud Carlos III (ES), Hospital de Sant Pau (ES), Bellvitge University Hospital (ES), Institut d'Investigació Biomédica de Bellvitge (ES), Peter Doherty Institute (AU), Centro de Investigación Biomédica en Red (ES), Hospital Clínic de Barcelona (ES), Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (ES), Hospital Universitari Germans Trias i Pujol (ES), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES), Sunnybrook Hospital (CA), Sunnybrook Research Institute, Universitat de Barcelona (ES)
Pfizer, AstraZeneca, Gilead Sciences, ViiV Healthcare, Genentech, Medical Research Council, National Health and Medical Research Council, Instituto de Salud Carlos III
Openalex Percentile: Top 10%
Antimicrobial Resistance in Staphylococcus
2.79
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.